AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
What are the pros and cons of bispecific antibodies for multiple myeloma?
Multiple Myeloma Hub
Introduction
Exploring the latest developments in utilizing bi-specific antibodies for Multiple Myeloma treatment as discussed by Dr. Roberto Mina and Professor Andrzej Jakoboviak, highlighting findings from the phase one Majestic trial with Elra Natham up at meetings such as ASCO 2022.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode